Bioprocessing companies develop and manufacture biological products using living organisms. This industry includes firms involved in drugs, vaccines, and new therapies. Companies focus on optimizing production processes to increase efficiency, enhance product quality, and reduce costs. Growing demand for personalized medicine and biologics is driving rapid advancements in technology and automation. Moreover, as regulatory environments tighten, these companies are adapting through innovations to ensure compliance while meeting market demands. Investors are keenly interested in this field due to its potential for significant returns and substantial societal impact, particularly in health advancement and disease treatment.

The firms listed comprise a blend of small-scale innovators and larger corporate entities, primarily located in the USA, Europe, and India. Ranging from established companies like FUJIFILM Diosynth, with thousands of employees, to emerging ventures such as OmniBRx in India, these businesses were founded between 1991 and 2023. They specialize in services and products like bioreactors, cell culture tools, and comprehensive bioprocessing solutions, reflecting a strong focus on technological advancement within the industry. Their size and specialization vary, highlighting a vibrant and evolving market dedicated to addressing modern healthcare challenges.

Continue reading to explore the top bioprocessing companies.

Top 15 Bioprocessing Companies Companies

1. FUJIFILM Diosynth Biotechnologies

• Website: fujifilmdiosynth.com
• Ownership type: Corporate
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: Denmark 43%, United States (USA) 40%, United Kingdom (UK) 17%
• Latest funding: $890.0M, August 2019
• Founded year: 2011
• Headcount: 1001-5000
• LinkedIn: fujifilm-diosynth-biotechnologies

FUJIFILM Diosynth Biotechnologies is a biotechnology company based in Morrisville, North Carolina, specializing in contract development and manufacturing services for biologics, vaccines, and advanced therapies. Founded in 2011, the company has quickly established itself as a key partner for pharmaceutical and biotechnology firms, providing essential expertise in cGMP processes to ensure the safe and effective delivery of products. With a workforce of over 5,000 employees distributed across facilities in the United States, Denmark, the United Kingdom, and Japan, FUJIFILM Diosynth Biotechnologies supports clients through all phases of drug development, from pre-clinical studies to commercialization. Their capabilities include mammalian cell culture, microbial fermentation, and advanced therapies such as gene and cell therapy. The company has made substantial investments in expanding its manufacturing capacity, including a recent commitment of $1.2 billion to enhance its large-scale cell culture operations in North Carolina, reflecting its strategic focus on meeting the growing demands of the bioprocessing market.

2. OmniBRx Biotechnologies Pvt Ltd

• Website: omnibrx.com
• Ownership type: Venture Capital
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 100%
• Latest funding: Series A, $3.6M, March 2023
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: omnibrx-biotechnologies

OmniBRx Biotechnologies Pvt Ltd, founded in 2016 and based in Ahmedabad, Gujarat, India, is a biotechnology firm dedicated to advancing bioprocessing technologies. The company specializes in innovative solutions for cell culture and therapeutic applications, providing products such as the CellBRx™ bioreactors and PerfBRx™ systems. These products are designed to enhance efficiency and scalability in drug development and production, catering to the needs of biopharmaceutical researchers and manufacturers. OmniBRx's technologies are particularly relevant for applications in cell therapies, therapeutic proteins, and vaccines. The company has recently raised approximately $3.6 million in Series A funding, reflecting investor confidence in its potential to impact the bioprocessing landscape significantly. With a workforce of around 42 employees, OmniBRx is positioned to make meaningful contributions to the bioprocessing industry.

3. PBS Biotech

• Website: pbsbiotech.com
• Ownership type: Venture Capital
• Headquarters: Camarillo, California, United States (USA)
• Employee distribution: United States (USA) 98%, Other 2%
• Latest funding: $17.0M, January 2025
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: pbs-biotech-inc.

PBS Biotech, Inc., founded in 2008 and based in Camarillo, California, is a biotechnology company that focuses on the development and manufacturing of bioreactors tailored for cell therapy processes. The company offers a range of products, including the PBS-80 and PBS-15 Vertical-Wheel Bioreactors, which are designed to facilitate large-scale manufacturing of therapeutic cells. These bioreactors are equipped with features that enhance process customization and control, making them suitable for both clinical and commercial production stages. PBS Biotech also provides process development services, helping clients in the biotechnology and pharmaceutical sectors to effectively scale up their cell culture processes. With a workforce of approximately 109 employees and a recent funding round of $17 million in January 2025, PBS Biotech demonstrates a solid commitment to innovation and growth within the bioprocessing industry.

4. BioProcess International

• Website: bioprocessintl.com
• Ownership type: Corporate
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: April 2015
• Founded year: 2002
• Headcount: 11-50
• LinkedIn: bioprocess-international

BioProcess International, based in Boston, Massachusetts, is a biotechnology company founded in 2002. It operates under the Informa Connect Division of Informa PLC. The company specializes in providing insights and resources related to bioprocessing and manufacturing within the biopharmaceutical industry. BioProcess International serves a niche market by offering a range of educational materials, including articles, webinars, and reports that tackle various challenges faced by biopharmaceutical companies and research institutions. Their content covers critical topics such as upstream and downstream processing, analytical methods, and manufacturing strategies, making them a key player in the knowledge-sharing aspect of the bioprocessing sector.

5. Ingenza Ltd

• Website: ingenza.com
• Ownership type: Private
• Headquarters: United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: Other (Debt), $2.5M, November 2024
• Founded year: 2002
• Headcount: 11-50
• LinkedIn: ingenza

Ingenza Ltd, founded in 2002 and based in Edinburgh, UK, is a biotechnology company that specializes in engineering biology for the production of therapeutics, enzymes, and consumer products. With a workforce of 11-50 employees, Ingenza operates as a contract development and manufacturing organization (CDMO), providing essential services in biomanufacturing, process development, and analytical chemistry. Their expertise supports biopharmaceutical companies in enhancing drug development processes. Ingenza's facility integrates molecular biology, fermentation, and analytical chemistry, allowing them to deliver comprehensive solutions for their clients. Recently, they secured funding of approximately £2.5 million, which underscores their growth and commitment to advancing bioprocessing technologies. Their case studies highlight successful projects in areas such as vaccine component production and protein solubility optimization, showcasing their capability to address complex challenges in the bioprocessing field.

6. Eppendorf Asia Pacific

• Website: eppendorf.com
• Ownership type: Private
• Headquarters: Petaling Jaya, Kuala Lumpur, Malaysia
• Founded year: 1945
• Headcount: 51-200
• LinkedIn: eppendorf-asia-pacific

Eppendorf Asia Pacific, based in Petaling Jaya, Kuala Lumpur, Malaysia, is a private life sciences company founded in 1945. The company develops and sells a range of laboratory instruments, consumables, and services, with a notable emphasis on bioprocess solutions. Their product line includes automated pipetting systems, bioprocess controllers, single-use bioreactors, and various laboratory consumables. Eppendorf caters to academic and commercial research laboratories, providing essential tools for liquid handling and sample analysis. Their global operations reflect a strong focus on innovation and quality, particularly in the bioprocessing sector, where they offer solutions that support pharmaceutical and biotechnology research and development.

7. KBI Biopharma

• Website: kbibiopharma.com
• Ownership type: Venture Capital
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 88%, Switzerland 12%
• Latest funding: December 2016
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: kbi-biopharma

KBI Biopharma, founded in 1996 and based in Durham, North Carolina, is a biopharmaceutical development and manufacturing company. The firm provides comprehensive services that include cell line development, process development, analytical development, and both clinical and commercial manufacturing. KBI Biopharma serves pharmaceutical and biotechnology companies, assisting them in navigating the complexities of drug development while ensuring adherence to regulatory standards. The company operates multiple facilities in the U.S. and Europe, emphasizing its global reach and operational capabilities. KBI Biopharma's innovative technologies, such as the SUREtechnology Platform and PUREplatform, are designed to enhance the efficiency and effectiveness of biopharmaceutical production. Their commitment to high standards and quality assurance is evident in their extensive service offerings, which cater to a variety of bioprocessing needs.

8. CEVEC Pharmaceuticals - now part of Cytiva

• Website: cevec.com
• Ownership type: Corporate
• Headquarters: Germany
• Latest funding: October 2022
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: cevec-pharmaceuticals-gmbh

CEVEC Pharmaceuticals, now integrated into Cytiva, is a biotechnology firm based in Germany that specializes in bioprocessing and gene therapy solutions. Founded in 2003, the company has developed a range of products and services aimed at enhancing therapeutic development processes for biopharmaceutical companies and research institutions. Their expertise lies in cell line development and viral vector manufacturing, particularly through their innovative ELEVECTA™ producer cell line technology, which allows for efficient AAV production without the need for plasmid transfection or helper viruses. This technology is crucial for advancing gene therapies, which have the potential to transform patient care. CEVEC's commitment to providing scalable and robust bioprocessing solutions positions them as a significant contributor to the biopharmaceutical industry.

9. PharmaFluidics

• Website: pharmafluidics.com
• Ownership type: Corporate
• Headquarters: Ghent, Flanders, Belgium
• Latest funding: November 2021
• Founded year: 2010
• Headcount: 11-50
• LinkedIn: pharmafluidics

PharmaFluidics, based in Ghent, Belgium, is a biotechnology company founded in 2010. The firm focuses on developing advanced chromatography solutions tailored for the biopharmaceutical industry. Their innovative technologies aim to enhance the efficiency and effectiveness of biomolecule purification processes. PharmaFluidics is particularly known for its contributions to the field of bioprocessing, providing tools that help streamline workflows and improve product quality. The company operates with a small team, emphasizing agility and specialized knowledge in its offerings. Although there is no recent funding reported, their ongoing activities and product development indicate a commitment to remaining active and relevant in the bioprocessing sector.

10. Scigenics (India) Pvt. Ltd.

• Website: scigenics.in
• Ownership type: Private
• Headquarters: Chennai, Tamil Nadu, India
• Employee distribution: India 100%
• Founded year: 1991
• Headcount: 51-200
• LinkedIn: scigenics-india-pvt-ltd

Scigenics (India) Pvt. Ltd., established in 1991, is a bioprocess equipment manufacturer based in Chennai, Tamil Nadu. The company specializes in designing and producing fermenters and bioreactors specifically for the life sciences sector. Scigenics serves a variety of clients in the pharmaceutical and biotech industries, offering tailored engineering solutions and comprehensive fermentation systems. With a strong emphasis on research and development, Scigenics aims to enhance bioprocessing capabilities for its customers. The company has built a significant installation base, boasting over 2000 fermenters deployed across India and internationally. Scigenics is recognized for its ability to design equipment suited for Indian tropical conditions, which is crucial for local clients. Their product range includes lab-scale, pilot-scale, and industrial-scale fermenters, as well as various upstream and downstream process vessels. The company also engages in training programs for bioscientists and technocrats, contributing to the academic and practical knowledge in the bioprocessing field.

11. Cellevate AB

• Website: cellevate.com
• Ownership type: Venture Capital
• Headquarters: Jönköping, Jonkoping, Sweden
• Employee distribution: Sweden 100%
• Latest funding: Other (Grant), April 2025
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: cellevate-ab

Cellevate AB, founded in 2014 and based in Jönköping, Sweden, is a biotechnology firm that specializes in the development and marketing of advanced cell culture systems for biomanufacturing. The company has developed a proprietary technology known as Cellevat3d®, which significantly enhances productivity in the production of gene therapies and vaccines. This technology is designed to improve cell viability and process efficiency, making it particularly valuable for biopharmaceutical firms and Contract Development and Manufacturing Organizations (CDMOs). Cellevate's innovative solutions are aimed at addressing the pressing challenges in biomanufacturing, such as scaling issues and high production costs. The company is preparing for the commercial launch of its nanofiber microcarriers, which are expected to revolutionize upstream bioprocessing by providing a scalable and sustainable option for cell culture. With a dedicated team and a clear focus on advancing life-changing therapies, Cellevate is positioned as a key player in the bioprocessing industry.

12. Culture Biosciences

• Website: culturebiosciences.com
• Ownership type: Venture Capital
• Headquarters: South San Francisco, California, United States (USA)
• Latest funding: Series B, $80.0M, October 2021
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: culture-robotics

Culture Biosciences, founded in 2016 and based in South San Francisco, California, is a bioprocess development company that offers a range of services aimed at optimizing the production of protein therapeutics and viral vectors. The company provides solutions such as clone screening, process development, and process characterization, all facilitated through their cloud-connected bioreactor systems. This technology allows for real-time monitoring and data analysis, which enhances the efficiency of bioprocessing. With a workforce of approximately 93 employees, Culture Biosciences has established itself as a significant player in the biotechnology and pharmaceutical sectors. The company has successfully attracted substantial investment, securing $80 million in a Series B funding round in October 2021, which underscores its growth potential and relevance in the industry.

13. Sunflower Therapeutics

• Website: sunflowertx.com
• Ownership type: Venture Capital
• Headquarters: Medford, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $3.0M, July 2024
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: sunflower-therapeutics

Sunflower Therapeutics, founded in 2018 and based in Medford, Massachusetts, is a biotechnology firm dedicated to transforming protein manufacturing. The company specializes in advanced bioreactor systems and bioprocessing software, aimed at biopharmaceutical companies, vaccine manufacturers, and research organizations. Their flagship products, the Daisy Petal™ and Dahlia Petal™ perfusion bioreactor systems, are designed to streamline the production process, making it more accessible and efficient. Sunflower's innovative approach includes the use of perfusion fermentation, which allows for continuous production and higher yields of proteins. With a team of 23 employees, the company is actively engaged in enhancing the development cycles for biologics, thereby supporting the broader healthcare and food industries. Recently, they secured $3 million in seed funding, underscoring their potential for growth and innovation in the bioprocessing field.

14. Stämm

• Website: stamm.bio
• Ownership type: Private
• Headquarters: San Francisco, California, United States (USA)
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: stammbiotech

Stämm is a biotechnology firm based in San Francisco, California, founded in 2016. The company focuses on biomanufacturing solutions, providing advanced technologies for the production of biologics and cell therapies. Stämm aims to optimize bioprocesses, enhance production efficiency, and ensure compliance with regulatory standards. Their flagship product, the Bioprocessor, is designed to facilitate continuous and automated production, allowing for improved process control and scalability. Stämm actively engages in the biotech community, participating in significant industry events and discussions, which highlights their commitment to innovation and collaboration in the bioprocessing field.

15. ProBioGen AG

• Website: probiogen.de
• Ownership type: Corporate
• Headquarters: Berlin, Berlin, Germany
• Employee distribution: Germany 100%
• Latest funding: June 2010
• Founded year: 1994
• Headcount: 201-500
• LinkedIn: probiogen-ag

ProBioGen AG, founded in 1994 and based in Berlin, Germany, is a biopharmaceutical company that specializes in contract development and manufacturing services. With a workforce of around 180 employees, the company has carved out a niche in the bioprocessing industry by offering a range of services that include GMP production, process development, and the creation of innovative technologies for therapeutic proteins and antibodies. ProBioGen's clientele primarily consists of biotech and pharmaceutical companies that rely on their expertise for efficient and reliable production processes. The company emphasizes quality and customer satisfaction, ensuring that their clients receive tailored solutions that meet specific needs. Their proprietary technologies, such as GlymaxX® for enhancing antibody potency and DirectedLuck® for transposase targeting, showcase their commitment to advancing biopharmaceutical development. ProBioGen has developed over 420 stable cell lines and has a proven track record in producing biosimilars and biobetters, further solidifying their position in the industry.

Bioprocessing Companies Insights: Key Companies

Want to Find More Bioprocessing Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!